Lansdale, PA, United States of America

Walter Rodriquez

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter Rodriquez: Innovator in Pharmaceutical Chemistry

Introduction

Walter Rodriquez is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important chemical compounds. His work has implications for the development of medications that target critical biological pathways.

Latest Patents

Walter Rodriquez holds a patent for the "Synthesis of aldehydes useful in the preparations of HMG-CoA reductase." This patent discloses a process for the preparation of 2-aryl-1-cyclohexene-1-carboxaldehydes from 1-arylcyclohexenes. These compounds serve as intermediates for the synthesis of trans-6-[(2-arylsubstituted cycloalkenyl and substituted cycloalkyl)alkenyl and alkyl]-3,4,5,6-tetrahydro-2H-pyran-2-ones, which are relevant in the pharmaceutical industry.

Career Highlights

Walter Rodriquez is associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has contributed to various research initiatives. His expertise in chemical synthesis has been instrumental in advancing the company's pharmaceutical projects.

Collaborations

Throughout his career, Walter has collaborated with esteemed colleagues, including Laurence W. Reilly and Thomas Goetzen. These partnerships have fostered innovation and enhanced the research output in their respective fields.

Conclusion

Walter Rodriquez is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in drug development. His patent and collaborations reflect his commitment to innovation in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…